• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铍病早期的病理和免疫学改变。对疾病定义和自然史的重新审视。

Pathologic and immunologic alterations in early stages of beryllium disease. Re-examination of disease definition and natural history.

作者信息

Newman L S, Kreiss K, King T E, Seay S, Campbell P A

机构信息

Department of Medicine, National Jewish Center for Immunology and Respiratory Medicine, Denver, CO 80206.

出版信息

Am Rev Respir Dis. 1989 Jun;139(6):1479-86. doi: 10.1164/ajrccm/139.6.1479.

DOI:10.1164/ajrccm/139.6.1479
PMID:2729754
Abstract

Beryllium lung disease is a chronic granulomatous disorder in which a beryllium-specific immune response plays a central role. By using a measure of cellular immune response to beryllium salts, bronchoalveolar lavage (BAL), and lung biopsy, we have identified 12 new cases of beryllium disease. Each of these individuals had pathologic changes on biopsy, lymphocytic alveolitis on BAL, and positive BAL lymphocyte transformation tests (LTT) in response to beryllium sulfate. This group of patients was remarkable for its paucity of clinical findings. At initial evaluation, seven had no respiratory symptoms, and four had normal physical examinations. Five had no increase in interstitial markings on chest radiograph. In eight cases, flow rates and lung volumes were normal. Diffusing capacity for carbon monoxide was low in only one case, and oxygen exchange during exercise was normal in six of nine subjects studied. In addition to the 12 cases, we evaluated eight beryllium-exposed workers who had other (nonberyllium) lung diseases; two of these eight demonstrated beryllium sensitization based on BAL LTT. We conclude that use of fiberoptic bronchoscopy with transbronchial biopsy and BAL facilitates diagnosis of beryllium workers who have histopathologic and immunologic alterations consistent with chronic beryllium disease. These findings may precede frank clinical illness and physiologic impairment, having important implications for our understanding of the natural history of beryllium disease.

摘要

铍肺疾病是一种慢性肉芽肿性疾病,其中铍特异性免疫反应起核心作用。通过采用对铍盐的细胞免疫反应测量、支气管肺泡灌洗(BAL)和肺活检,我们已确诊12例新的铍病病例。这些个体每一个在活检时都有病理改变,BAL时有淋巴细胞性肺泡炎,并且对硫酸铍的BAL淋巴细胞转化试验(LTT)呈阳性。这组患者的临床症状非常少。在初次评估时,7人无呼吸道症状,4人体格检查正常。5人胸部X线片上无肺间质纹理增粗。8例患者的流速和肺容量正常。仅1例一氧化碳弥散量降低,在研究的9名受试者中,6人运动时的氧交换正常。除了这12例病例外,我们还评估了8名接触铍且患有其他(非铍)肺部疾病的工人;这8人中2人基于BAL LTT显示铍致敏。我们得出结论,使用纤维支气管镜进行经支气管活检和BAL有助于诊断那些具有与慢性铍病一致的组织病理学和免疫学改变的铍接触工人。这些发现可能先于明显的临床疾病和生理损害,对我们理解铍病的自然史具有重要意义。

相似文献

1
Pathologic and immunologic alterations in early stages of beryllium disease. Re-examination of disease definition and natural history.铍病早期的病理和免疫学改变。对疾病定义和自然史的重新审视。
Am Rev Respir Dis. 1989 Jun;139(6):1479-86. doi: 10.1164/ajrccm/139.6.1479.
2
Compartmentalized immune response reflects clinical severity of beryllium disease.区室化免疫反应反映了铍病的临床严重程度。
Am J Respir Crit Care Med. 1994 Jul;150(1):135-42. doi: 10.1164/ajrccm.150.1.8025739.
3
Beryllium sensitization progresses to chronic beryllium disease: a longitudinal study of disease risk.铍致敏进展为慢性铍病:疾病风险的纵向研究
Am J Respir Crit Care Med. 2005 Jan 1;171(1):54-60. doi: 10.1164/rccm.200402-190OC. Epub 2004 Sep 16.
4
Early pulmonary physiologic abnormalities in beryllium disease.铍病早期的肺部生理异常。
Am Rev Respir Dis. 1993 Sep;148(3):661-6. doi: 10.1164/ajrccm/148.3.661.
5
Beryllium-stimulated release of tumor necrosis factor-alpha, interleukin-6, and their soluble receptors in chronic beryllium disease.铍刺激慢性铍病中肿瘤坏死因子-α、白细胞介素-6及其可溶性受体的释放。
Am J Respir Crit Care Med. 1997 Dec;156(6):1884-91. doi: 10.1164/ajrccm.156.6.9610040.
6
Serum angiotensin converting enzyme activity in chronic beryllium disease.慢性铍病患者血清血管紧张素转换酶活性
Am Rev Respir Dis. 1992 Jul;146(1):39-42. doi: 10.1164/ajrccm/146.1.39.
7
Screening blood test identifies subclinical beryllium disease.血液筛查检测可识别亚临床铍病。
J Occup Med. 1989 Jul;31(7):603-8. doi: 10.1097/00043764-198907000-00011.
8
A canine model of beryllium-induced granulomatous lung disease.铍诱导的肉芽肿性肺病的犬模型。
Lab Invest. 1989 Aug;61(2):219-27.
9
An immune model of beryllium-induced pulmonary granulomata in mice. Histopathology, immune reactivity, and flow-cytometric analysis of bronchoalveolar lavage-derived cells.小鼠铍诱导肺肉芽肿的免疫模型。支气管肺泡灌洗来源细胞的组织病理学、免疫反应性及流式细胞术分析。
Lab Invest. 1992 Jul;67(1):138-46.
10
Nonoccupational beryllium disease masquerading as sarcoidosis: identification by blood lymphocyte proliferative response to beryllium.伪装成结节病的非职业性铍病:通过血液淋巴细胞对铍的增殖反应进行识别
Am Rev Respir Dis. 1992 May;145(5):1212-4. doi: 10.1164/ajrccm/145.5.1212.

引用本文的文献

1
Fibrotic pulmonary dust foci is an advanced pneumoconiosis lesion in rats induced by titanium dioxide nanoparticles in a 2-year inhalation study.纤维化肺尘埃病灶是二氧化钛纳米颗粒在一项为期两年的吸入研究中诱导大鼠产生的晚期尘肺病病变。
Part Fibre Toxicol. 2025 Apr 18;22(1):7. doi: 10.1186/s12989-025-00623-y.
2
Pathology and Mineralogy of the Pneumoconioses.尘肺的病理学和矿物学。
Semin Respir Crit Care Med. 2023 Jun;44(3):327-339. doi: 10.1055/s-0043-1764406. Epub 2023 Mar 27.
3
Pulmonary dust foci as rat pneumoconiosis lesion induced by titanium dioxide nanoparticles in 13-week inhalation study.
13 周吸入研究中二氧化钛纳米颗粒致大鼠尘肺病变的肺尘埃沉着灶。
Part Fibre Toxicol. 2022 Sep 14;19(1):58. doi: 10.1186/s12989-022-00498-3.
4
Innate and Adaptive Immunity in Noninfectious Granulomatous Lung Disease.非感染性肉芽肿性肺病中的固有免疫和适应性免疫。
J Immunol. 2022 Apr 15;208(8):1835-1843. doi: 10.4049/jimmunol.2101159.
5
Beryllium-specific CD4+ T cells induced by chemokine neoantigens perpetuate inflammation.趋化因子新抗原诱导的铍特异性 CD4+T 细胞持续炎症。
J Clin Invest. 2021 May 3;131(9). doi: 10.1172/JCI144864.
6
Sarcoidosis: a prospective observational cohort from Northern Alberta.结节病:来自阿尔伯塔省北部的前瞻性观察队列研究。
Sarcoidosis Vasc Diffuse Lung Dis. 2020;37(4):e2020014. doi: 10.36141/svdld.v37i4.8522. Epub 2020 Dec 16.
7
Sarcoidosis: Pitfalls and Challenging Mimickers.结节病:陷阱与具有挑战性的模仿者
Front Med (Lausanne). 2021 Jan 11;7:594275. doi: 10.3389/fmed.2020.594275. eCollection 2020.
8
Adaptive Immunity in Pulmonary Sarcoidosis and Chronic Beryllium Disease.肺结节病和慢性铍病中的适应性免疫。
Front Immunol. 2020 Mar 18;11:474. doi: 10.3389/fimmu.2020.00474. eCollection 2020.
9
5-Aminosalicylic Acid Modulates the Immune Response in Chronic Beryllium Disease Subjects.5-氨基水杨酸调节慢性铍病患者的免疫反应。
Lung. 2018 Feb;196(1):103-114. doi: 10.1007/s00408-017-0062-x. Epub 2017 Oct 27.
10
Beryllium-Induced Hypersensitivity: Genetic Susceptibility and Neoantigen Generation.铍诱导的超敏反应:遗传易感性与新抗原生成
J Immunol. 2016 Jan 1;196(1):22-7. doi: 10.4049/jimmunol.1502011.